Detail page

Knowledge Web

Person

Markus Graefen

Urologe

Name	Markus Graefen
Place	Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Urologe (characteristic profession) Arzt
Related	Universitätsklinikum Hamburg-Eppendorf
Further information	Univ. Hamburg, Medizinische Fak., Universitätsklinikum Hamburg-Eppendorf, Zentrum für Operative Medizin, Klinik und Poliklinik für Urologie, 1995-; seit 2001 Oberarzt und Leiter der Prostatakarzinom-Sondersprechstunde; seit 2004 Chefarzt an der Martini-Klinik im UKE
Source	http://www.martini-klinik.de/die-martini-klinik/team/aerzte/leitende-aerzte/graefen/?L=tzomkxilm.html.html.html
Record type	Person
GND-Identifier	1027188648
Record ID	1027188648
Involved in show all Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy? Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients Adverse in-hospital outcomes after radical prostatectomy in leukemia history patients Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomy Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs? Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: an observational studys Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis Preprostatic lymph nodes in prostate cancer hot or not? Impact on oncological outcome after radical prostatectomy Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center Radiation therapy after radical prostatectomy is associated with higher other-cause mortality Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients Chirurgische Aspekte der Behandlung des Prostatakarzinoms Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer Urethral sphincter length but not prostatic apex shape in preoperative MRI is associated with mid-term continence rates after radical prostatectomy Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy Die erhöhte Proteinexpression des Transkriptionsfaktors TFAP2D ist mit einem aggressiven Tumorphänotyp des Prostatakarzinoms ohne ERG-Fusion assoziiert Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy External beam radiotherapy and radical prostatectomy are associated with better survival in asian prostate cancer patients External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Markus Graefen

Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience

Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma

PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?

Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients

Adverse in-hospital outcomes after radical prostatectomy in leukemia history patients

Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients

Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer

Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomy

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: an observational studys

Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy

Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis

Preprostatic lymph nodes in prostate cancer hot or not? Impact on oncological outcome after radical prostatectomy

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients

Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy

Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables

Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients

Chirurgische Aspekte der Behandlung des Prostatakarzinoms

Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups

Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy

Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients

Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis

Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients

Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer

Urethral sphincter length but not prostatic apex shape in preoperative MRI is associated with mid-term continence rates after radical prostatectomy

Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients

Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities

The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy

Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review

Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients

Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients

Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy

Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy

Die erhöhte Proteinexpression des Transkriptionsfaktors TFAP2D ist mit einem aggressiven Tumorphänotyp des Prostatakarzinoms ohne ERG-Fusion assoziiert

Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

External beam radiotherapy and radical prostatectomy are associated with better survival in asian prostate cancer patients

External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients

Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making

Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients

Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant

Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores

Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer

Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis